From Euphoria To Reality: Viatris' Tale Of Market Whirlwind

Maca and Naca/E+ via Getty Images Viatris Inc. (NASDAQ:VTRS) is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. The company is one of the leaders in the generics industry. Thesis Over the past two and a half months, Viatris' share price has risen more than 38%, reflecting increasing sales of its branded drugs in recent quarters, stock market euphoria about the expected Fed interest-rate cuts in 2024, and statements from its management, which anticipates the company t ...